- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Ophthalmic vein.
Displaying page 1 of 1.
EudraCT Number: 2004-002502-29 | Sponsor Protocol Number: 206207-009 | Start Date*: 2004-12-08 |
Sponsor Name:Allergan Limited | ||
Full Title: A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segm... | ||
Medical condition: Macular edema due to Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006265-93 | Sponsor Protocol Number: AVO1 | Start Date*: 2009-03-11 |
Sponsor Name:St Eriks Eye Hospital | ||
Full Title: A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin®) for central retinal vein occlusion (CRVO). | ||
Medical condition: Central retinal vein occlusion (CRVO) is a sight-threatening ocular condition without efficient treatment. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000425-72 | Sponsor Protocol Number: RET-01-11 | Start Date*: 2011-01-25 | |||||||||||
Sponsor Name:IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | |||||||||||||
Full Title: Treatment of macular edema secondary to central or branch vein occlusion by dexamethazone intravitreal injection | |||||||||||||
Medical condition: macular edema seconday to central or branch retinal vein occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001061-37 | Sponsor Protocol Number: KS301P103 | Start Date*: 2020-12-11 | |||||||||||||||||||||||||||||||
Sponsor Name:Kodiak Sciences Inc. | |||||||||||||||||||||||||||||||||
Full Title: A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared with Intravitreal A... | |||||||||||||||||||||||||||||||||
Medical condition: Macular edema secondary to retinal vein occlusion | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: LV (Prematurely Ended) DE (Completed) SK (Prematurely Ended) CZ (Prematurely Ended) FR (Prematurely Ended) HU (Completed) IT (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-005486-13 | Sponsor Protocol Number: 12-EI-0134 | Start Date*: 2013-02-25 | |||||||||||
Sponsor Name:The National Eye Institute | |||||||||||||
Full Title: A Phase II Randomized Study to Compare Anti-VEGF Agents in the Treatment of Diabetic Macular Edema (CADME) | |||||||||||||
Medical condition: Diabetic Macular Edema (DME) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005364-57 | Sponsor Protocol Number: HLX04-O-wAMD | Start Date*: 2021-04-06 | |||||||||||
Sponsor Name:Shanghai Henlius Biotech. Inc. | |||||||||||||
Full Title: A Phase 3, Two-part (Open-label Followed by Randomized Double-masked Active Controlled) Study to Compare the Efficacy and Safety of HLX04-O Administered by Intravitreal Injection with ranibizumab i... | |||||||||||||
Medical condition: Wet Age-related Macular Degeneration (wAMD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) HU (Completed) CZ (Prohibited by CA) PL (Completed) ES (Ongoing) SK (Completed) BG (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000113-31 | Sponsor Protocol Number: TED01RV | Start Date*: 2014-07-14 | |||||||||||
Sponsor Name:River Vision Development Corporation | |||||||||||||
Full Title: A randomized, double-masked, placebo-controlled, efficacy and safety study of RV 001, an insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody (fully human), administered every 3 weeks... | |||||||||||||
Medical condition: Thyroid-Associated Ophthalmopathy / Graves' Ophthalmopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
